4th Quarter - Report
W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Educated staff about access to therapies for rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures). Education about the value of innovative new medicines.H.R. 1281: Newborn Screening Saves Lives Reauthorization Act of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.